4.99
price up icon3.31%   0.16
after-market After Hours: 4.88 -0.11 -2.20%
loading
Eledon Pharmaceuticals Inc stock is traded at $4.99, with a volume of 384.96K. It is up +3.31% in the last 24 hours and up +90.46% over the past month. Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
See More
Previous Close:
$4.83
Open:
$4.82
24h Volume:
384.96K
Relative Volume:
1.26
Market Cap:
$288.54M
Revenue:
-
Net Income/Loss:
$-40.33M
P/E Ratio:
-0.8358
EPS:
-5.97
Net Cash Flow:
$-39.53M
1W Performance:
+39.00%
1M Performance:
+90.46%
6M Performance:
+107.05%
1Y Performance:
+305.69%
1-Day Range:
Value
$4.7577
$5.38
1-Week Range:
Value
$3.50
$5.54
52-Week Range:
Value
$1.07
$5.54

Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile

Name
Name
Eledon Pharmaceuticals Inc
Name
Phone
949-238-8090
Name
Address
19800 MACARTHUR BLVD., IRVINE
Name
Employee
20
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
ELDN's Discussions on Twitter

Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades

Date Action Analyst Rating Change
May-13-22 Resumed Cantor Fitzgerald Overweight
Mar-23-21 Initiated Cantor Fitzgerald Overweight

Eledon Pharmaceuticals Inc Stock (ELDN) Latest News

pulisher
Oct 31, 2024

Biotechnology Value Fund L P's Strategic Acquisition in Eledon P - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

ELDN stock touches 52-week high at $4.13 amid robust gains - Investing.com Australia

Oct 31, 2024
pulisher
Oct 30, 2024

ELDN stock touches 52-week high at $4.13 amid robust gains By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

SEC Form 424B5 filed by Eledon Pharmaceuticals Inc. - Quantisnow

Oct 30, 2024
pulisher
Oct 30, 2024

Eledon drug helps transplants 'cure' type 1 diabetes - pharmaphorum

Oct 30, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals sets terms for $85 million stock offering By Investing.com - Investing.com South Africa

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon: Changing Scope Of Immunosuppressive Drug Space With Tegoprubart (ELDN) - Seeking Alpha

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Shares Hit 52-Week High After Positive Trial Data - MarketWatch

Oct 29, 2024
pulisher
Oct 29, 2024

Promising results for diabetes treatment with new drug By Investing.com - Investing.com Australia

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals sets terms for $85 million stock offering - Investing.com India

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine - The Manila Times

Oct 29, 2024
pulisher
Oct 29, 2024

Promising results for diabetes treatment with new drug - Investing.com India

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Pricing of $85 Million - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Positive Initial Data from - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - StockTitan

Oct 29, 2024
pulisher
Oct 26, 2024

Algorae Pharmaceuticals Plans Major Securities Issuance - MSN

Oct 26, 2024
pulisher
Oct 25, 2024

Midday Stock Roundup: The Ensign Group Beats Q3 Expectations - Orange County Business Journal

Oct 25, 2024
pulisher
Oct 23, 2024

ELDN stock soars to 52-week high, touches $3.35 amid surge - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

ELDN stock soars to 52-week high, touches $3.35 amid surge By Investing.com - Investing.com South Africa

Oct 23, 2024
pulisher
Oct 04, 2024

Financial Analysis: Eledon Pharmaceuticals (NASDAQ:ELDN) & ABVC BioPharma (NASDAQ:ABVC) - Defense World

Oct 04, 2024
pulisher
Oct 03, 2024

IgA nephropathy Clinical Trials 2024 (Updated): FDA Approvals, - openPR

Oct 03, 2024
pulisher
Oct 01, 2024

Eledon Pharmaceuticals completes $4 million equity sale - Investing.com India

Oct 01, 2024
pulisher
Oct 01, 2024

Eledon Pharmaceuticals completes $4 million equity sale By Investing.com - Investing.com South Africa

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Invests $1.58 Million in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Acquires New Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - MarketBeat

Oct 01, 2024
pulisher
Sep 28, 2024

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Short Interest Update - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Midday Stock Roundup: STAAR Surgical CO. Shares Surge 22% - Orange County Business Journal

Sep 27, 2024
pulisher
Sep 20, 2024

Eledon Pharmaceuticals initiates $75 million stock sale agreement By Investing.com - Investing.com Australia

Sep 20, 2024
pulisher
Sep 20, 2024

Eledon Pharmaceuticals initiates $75 million stock sale agreement - Investing.com

Sep 20, 2024
pulisher
Sep 11, 2024

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference - GlobeNewswire

Sep 11, 2024
pulisher
Sep 04, 2024

ELDNEledon Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Sep 04, 2024
pulisher
Sep 04, 2024

Eledon Announces Completion of Enrollment in Phase 2 BESTOW - GlobeNewswire

Sep 04, 2024
pulisher
Sep 04, 2024

Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients - StockTitan

Sep 04, 2024
pulisher
Sep 02, 2024

Short Interest in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Declines By 6.8% - MarketBeat

Sep 02, 2024
pulisher
Aug 23, 2024

Analysts Issue Forecasts for Eledon Pharmaceuticals, Inc.'s Q3 2024 Earnings (NASDAQ:ELDN) - MarketBeat

Aug 23, 2024
pulisher
Aug 23, 2024

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Expected to Earn Q3 2024 Earnings of ($0.20) Per Share - Defense World

Aug 23, 2024
pulisher
Aug 20, 2024

Vanguard Group Inc. Has $2 Million Stock Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - MarketBeat

Aug 20, 2024
pulisher
Aug 19, 2024

S&P 500 Information Technology [Sector] (SRIT) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 19, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 19, 2024

TSX Consumer Discretionary Capped Index (TTCD) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 19, 2024

2 'Strong Buy'-Rated Stocks That Wall Street Believes Can Soar Over 360% - TradingView

Aug 19, 2024
pulisher
Aug 19, 2024

TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 19, 2024

Eledon Pharmaceuticals Inc (ELDN-Q) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 14, 2024

Eledon Expects to Restate Results, Delays Quarterly Report - MarketWatch

Aug 14, 2024
pulisher
Aug 14, 2024

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results - GlobeNewswire

Aug 14, 2024
pulisher
Aug 02, 2024

Eledon Pharmaceuticals (NASDAQ:ELDN) Stock Price Down 1.7% - MarketBeat

Aug 02, 2024
pulisher
Aug 02, 2024

Eledon Pharmaceuticals (NASDAQ:ELDN) Shares Down 1.7% - Defense World

Aug 02, 2024
pulisher
Jul 29, 2024

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial - GlobeNewswire

Jul 29, 2024
pulisher
Jul 29, 2024

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection - Yahoo Finance

Jul 29, 2024
pulisher
Jul 26, 2024

Midday Stock Roundup: BJ’s Drops on Revenue Miss - Orange County Business Journal

Jul 26, 2024
pulisher
Jul 24, 2024

4 High-Risk, High-Reward Small-Cap Stocks to Play the Rotation - Investing.com

Jul 24, 2024

Eledon Pharmaceuticals Inc Stock (ELDN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):